| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/08/2006 | US20060121562 Human receptor tyrosine kinase mertk |
| 06/08/2006 | US20060121561 Gene for increased somatic recombination |
| 06/08/2006 | US20060121554 Regulation of human RTA-like GPCR |
| 06/08/2006 | US20060121552 Reporter protein fused to at least one protease cleavage sequence, and a linker for attaching the protease cleavage sequence to a solid support, can be used to quantitate protease activity, as well as be used to identify the type of protease being assayed |
| 06/08/2006 | US20060121546 For detection of caspases, trypsin and tryptase; comprises luciferase and amino-modified aminoluciferin or a carboxy-terminal protected derivative; solid phase synthesis |
| 06/08/2006 | US20060121545 Rapamycin conjugates and antibodies |
| 06/08/2006 | US20060121539 Eph receptor tumor biomarkers |
| 06/08/2006 | US20060121538 Peptides having affinity for the gp120 viral protein and use thereof |
| 06/08/2006 | US20060121529 CpG receptor (CpG-R) and methods relating thereto |
| 06/08/2006 | US20060121523 Transporter genes OATP-B, C, D, and E |
| 06/08/2006 | US20060121516 using amplification oligomers and polymerase; hybridization; kits; efficient and sensitive; useful in determining efficacy of vaccination |
| 06/08/2006 | US20060121514 Prostacyclin-stimulating Factor-2 |
| 06/08/2006 | US20060121513 Nuclear targeting sequence |
| 06/08/2006 | US20060121508 Alternatively spliced isoforms of purinergic receptor P2X, ligand-gated ion channel, subunits 3 and 4 (P2RX3, P2RX4) |
| 06/08/2006 | US20060121505 Beta chain-associated regulator of apoptosis |
| 06/08/2006 | US20060121498 Enzymes involved in apoptosis |
| 06/08/2006 | US20060121491 Partially degenerate oligonucleotide standards and methods for generating the same |
| 06/08/2006 | US20060121488 Glutamate transport modulatory compounds and methods |
| 06/08/2006 | US20060121484 From mouse bone marrow; immunoglobulins; vectors, host cells; allergies |
| 06/08/2006 | US20060121476 Cancer associated antigens, sga-56m and sga-56mv, and uses thereof |
| 06/08/2006 | US20060121472 Method for determining the allelic state of the 5'-end of the $g(a)s1- casein gene |
| 06/08/2006 | US20060121471 Gene families associated with stomach cancer |
| 06/08/2006 | US20060121468 Viruses and virus-like particles for multiple antigen and target display |
| 06/08/2006 | US20060121460 Toll-like receptor 11 |
| 06/08/2006 | US20060121459 Receptors and membrane-associated proteins |
| 06/08/2006 | US20060121456 Isolated human ras-like proteins acid molecules encoding these human ras-like proteins, and uses thereof |
| 06/08/2006 | US20060121454 diagnosis and treatment of carcinomas, especially breast cancers |
| 06/08/2006 | US20060121448 Method for inducing complete hepatitis c virus (hcv) replication in vitro |
| 06/08/2006 | US20060121447 Purified subfragment codifying for neuroaminidase, recombinant neuroaminidase and its use in zooprophylaxis |
| 06/08/2006 | US20060121117 Anti-angiogenic compositions and methods of use |
| 06/08/2006 | US20060121063 Group 2 mite polypeptide variants |
| 06/08/2006 | US20060121062 Conjugated hydroxyalkyl starch allergen compounds |
| 06/08/2006 | US20060121056 Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics |
| 06/08/2006 | US20060121051 Heat shock fusion-based vaccine system |
| 06/08/2006 | US20060121050 Fusion protein comprising bacillus calmette guerin heat shock protein 65 and the epitope of human prostate specific antigen |
| 06/08/2006 | US20060121049 Chimeric recombinant protein and in vitro diagnosis |
| 06/08/2006 | US20060121048 Encoding at least two full-length mannose-6-phosphate receptors in the antisense configuration, vaccines |
| 06/08/2006 | US20060121047 Use of hmgb polypetides for increasing immune responses |
| 06/08/2006 | US20060121046 Polypeptide comprising the immunogenic portion of wilms' tumor suppressor gene(wt1); tumor-associated antigen for use in cancer immunotherapy |
| 06/08/2006 | US20060121037 Anti-TNF antibodies and peptides of human tumor necrosis factor |
| 06/08/2006 | US20060121031 Relay vaccine |
| 06/08/2006 | US20060121025 VEGF-related protein |
| 06/08/2006 | US20060120999 Protein and peptide expression for passive immunity |
| 06/08/2006 | US20060120998 Deamidated interferon-beta |
| 06/08/2006 | CA2601629A1 Anti-hiv drug, polypeptide constituting the same, gene encoding the polypeptide and method of producing the anti-hiv drug |
| 06/08/2006 | CA2595115A1 Fusion proteins for treating, preventing or ameliorating pain |
| 06/08/2006 | CA2593707A1 Fusion proteins comprising a non-cytotoxic protease, a targeting moiety, a protease cleavage site and a translocation domain |
| 06/08/2006 | CA2590419A1 Modulation of ovulation |
| 06/08/2006 | CA2589902A1 Glucose-transport related genes, polypeptides, and methods of use thereof |
| 06/08/2006 | CA2589898A1 Modulation of ovulation |
| 06/08/2006 | CA2589187A1 Protein allergen derivatives |
| 06/08/2006 | CA2588900A1 Novel mutation involved in increased tolerance to imidazolinone herbicides in plants |
| 06/08/2006 | CA2588330A1 Methods of increasing seed yield with a growth eif-5a |
| 06/08/2006 | CA2588292A1 Non-cytotoxic protein conjugates |
| 06/08/2006 | CA2587382A1 Novel peptides that bind to the erythropoietin receptor |
| 06/08/2006 | CA2575924A1 Toxin compounds with enhanced membrane translocation characteristics |
| 06/08/2006 | CA2489940A1 Relay vaccine |
| 06/07/2006 | EP1666601A1 Transformant having an increased frequency of homologous recombination |
| 06/07/2006 | EP1666598A1 Nucleic acid and gene originating in novel hcv strain and replicon-replicating cell using the gene |
| 06/07/2006 | EP1666597A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2006 | EP1666596A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2006 | EP1666595A1 GAB2 (P97) gene and methods of use thereof |
| 06/07/2006 | EP1666594A2 Polypeptide, nucleic acid encoding it, and their use for the diagnosis of cancer |
| 06/07/2006 | EP1666592A1 A fungal immuromodulatory protein produced by microorganisme and uses there of |
| 06/07/2006 | EP1666591A1 Cytokine that induces apoptosis |
| 06/07/2006 | EP1666588A1 Novel transporter protein |
| 06/07/2006 | EP1666499A2 Novel inhibitors of vascular endothelial growth factor activity, their uses and processes for their production |
| 06/07/2006 | EP1666498A2 Soluble CTLA4 molecules, compositions comprising said molecules and uses thereof |
| 06/07/2006 | EP1666497A2 Polypeptide, nucleic acid encoding it, and their use for the diagnosis of cancer |
| 06/07/2006 | EP1666496A1 Interferon-beta composite |
| 06/07/2006 | EP1666495A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2006 | EP1666494A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2006 | EP1666493A1 Secreted and transmembrane polypeptides and nucleic acids ancoding the same |
| 06/07/2006 | EP1666492A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2006 | EP1666491A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2006 | EP1666490A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/07/2006 | EP1666489A1 DNA encoding an antigenic protein of eimeria apical membrane antigen 1 and use thereof |
| 06/07/2006 | EP1666488A1 Fluorescent protein |
| 06/07/2006 | EP1666487A1 Purification of hbv antigens for use in vaccines |
| 06/07/2006 | EP1666062A2 Therapeutic applications for the anti-T-BAM (CD40-L) monoclonal antibody 5c8 |
| 06/07/2006 | EP1666058A2 Method of and compositions for immunization with the pseudomonas V antigen |
| 06/07/2006 | EP1666052A1 Uses of agonists and antagonists to modulate activity of TNF-related molecules |
| 06/07/2006 | EP1666048A2 Method for producing insulin from a natural source and insulin |
| 06/07/2006 | EP1664795A2 Diagnostic method for brain damage-related disorders |
| 06/07/2006 | EP1664769A2 Assay for detecting atrial and brain natriuretic peptide prohormones |
| 06/07/2006 | EP1664346A2 Compositions, reagents and kits for and methods of diagnosing, monitoring and treating obesity and/or diabetes |
| 06/07/2006 | EP1664333A2 High-throughput-assay with high sensitivity for measuring of the activity of beta-adrenergic receptor kinase and for determining the impact of test substances on such activity |
| 06/07/2006 | EP1664324A1 Mutations in ion channels |
| 06/07/2006 | EP1664322A2 Recombinant carrier molecule for expression, delivery and purification of target polypeptides |
| 06/07/2006 | EP1664318A2 L-amino acid-producing microorganism and method for producing l-amino acid |
| 06/07/2006 | EP1664313A2 Excretable reporter systems |
| 06/07/2006 | EP1664310A2 Expansin polypeptides |
| 06/07/2006 | EP1664308A1 Nucleotide sequences and polypeptides encoded thereby useful for increasing plant size and increasing the number and size of leaves |
| 06/07/2006 | EP1664302A1 Flagellar genetic sequences of brucella being of therapeutic and diagnostic use |
| 06/07/2006 | EP1664301A1 Novel rat calcium channel subunits and related probes, cell lines and methods |
| 06/07/2006 | EP1664300A1 A new class of a2delta calcium channel subunits |
| 06/07/2006 | EP1664294A2 Regulation of cardiac contractility and heart failure propensity |
| 06/07/2006 | EP1664289A2 Cyclic nucleotide-specific phosphodiesterases from leishmania and uses thereof |
| 06/07/2006 | EP1664288A2 Mylks as modifiers of branching morphogenesis and methods of use |
| 06/07/2006 | EP1664284A1 Isolated nucleic acid molecules from the genome of citrus sudden death virus and uses thereof |